SAGE Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good morning, everyone, from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Sage Pharmaceuticals and CEO, Barry Greene. (Operator Instructions)
So with that, Barry, thanks for being here today, and let me hand things over to you.
Thanks, Cory, and thanks to the organizers of JPMorgan for having us here at the first ever virtual JPMorgan meeting. You guys have done a good job. It's certainly been very efficient.
Before I begin, I will be making forward-looking statements. So as Cory said, I'm Barry Greene, CEO of Sage Therapeutics, and it's my pleasure to provide an update on the extraordinary progress that Sage has made on brain health over the last decade, and importantly, provide my thoughts on what I believe our next chapter will be. At Sage, it's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
